Novadaq Technologies Inc. Expected to Earn Q2 2017 Earnings of ($0.28) Per Share (NDQ)
Novadaq Technologies Inc. (TSE:NDQ) (NASDAQ:NVDQ) – Analysts at Wedbush lowered their Q2 2017 earnings per share (EPS) estimates for Novadaq Technologies in a note issued to investors on Monday. Wedbush analyst Levy. T now expects that the company will earn ($0.28) per share for the quarter, down from their previous estimate of ($0.27). Wedbush currently has a “Neutral” rating on the stock. Wedbush also issued estimates for Novadaq Technologies’ Q3 2017 earnings at ($0.24) EPS, Q4 2017 earnings at ($0.16) EPS, FY2017 earnings at ($1.02) EPS and FY2018 earnings at ($0.65) EPS.
NDQ has been the subject of several other reports. William Blair reaffirmed a “market perform” rating on shares of Novadaq Technologies in a research report on Wednesday, May 3rd. Scotiabank reduced their target price on Novadaq Technologies to C$15.50 and set an “outperform” rating for the company in a research report on Tuesday. Craig Hallum reaffirmed a “buy” rating on shares of Novadaq Technologies in a research report on Thursday, May 4th. Finally, Royal Bank Of Canada reduced their target price on Novadaq Technologies to C$16.00 and set an “outperform” rating for the company in a research report on Wednesday, March 1st. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of C$16.17.
TRADEMARK VIOLATION WARNING: This piece was published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/06/21/novadaq-technologies-inc-expected-to-earn-q2-2017-earnings-of-0-28-per-share-ndq.html.
About Novadaq Technologies
NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.
Receive News & Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.